1. Adamietz IA, Baum RP, Schemman F, Niesen A, Knecht R, Saran F, Tieku S, Böniface GR, Hör G, Bottcher HD (1996) Improvement of radiation treatment planning in squamous-cell head and neck cancer by immuno-SPECT. JNucl Med 37:1942–1946
2. Ali S, Tiwari RM, Snow GB (1985) False positive and false negative neck nodes Head Neck Surg 8:78–82
3. Balm AJM, Hageman PC, Mulder CJ, Hilkens J (1992) Carcinoma-associated monoclonal antibodies in head and neck carcinoma:immunohistochemistry and biodistribution of monoclonal antibodies 175F4 and 175F11. Eur Arch Otorhinolaryngol 249:237–242
4. Baum RP, Adams S, Kiefer J, Niesen A, Knecht R, Howaldt H- P, Hertel A, Adamietz I A, Sykes T, Boniface GR, Noujaim AA, Hor G (1993) A novel Technetium-99m labeled monoclonal antibody (174H.64) for staging head and neck cancer by immuno-SPECT. Acta Oncol 32:747–751
5. Behr TM, Sharkey RM, Juweid ME, Dunn RM, Ying Z, Zhang CH, Siegel J A, Goldenberg DM (1997) Variables influencing tumor dosimetry in radioimmunotherapy of CEA-ex- pressing cancers with anti-CEA and antimucin monoclonal antibodies. J Nucl Med 38:409 - 418